Yixuan Liu
No. 348 Heping West Road
Shijiazhuang, 050051, China
Shijiazhuang, 050051, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
P1D6 inhibits FnBP-induced extracellular proteome remodeling: proteomic evidence for a novel intervention strategy in atopic dermatitis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: June 18, 2026
Biomimetic Multimodal Evaluation Reveals Enhanced Efficacy and Safety of Cyclosporine A Nanomicelles (CycloNex) for Advanced Dry Eye Management.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 05, 2026
Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren's syndrome.
Journal: Frontiers in immunology
Published: January 15, 2025
miR-216a-3p alleviates primary Sjögren's syndrome by regulating the STAT1/JAK signaling pathway.
Journal: Biochemical and biophysical research communications
Published: December 11, 2024
CAV1 and KRT5 are potential targets for prostate cancer.
Journal: Medicine
Published: December 08, 2023
Anticentromere antibody positive patients with primary Sjögren's syndrome have distinctive clinical and immunological characteristics.
Journal: Clinical and experimental rheumatology
Published: November 24, 2022
Interstitial lung disease in Primary Sjögren's syndrome.
Journal: BMC pulmonary medicine
Published: November 13, 2021
Hypocomplementemia in primary Sjogren's syndrome: association with serological, clinical features, and outcome.
Journal: Clinical rheumatology
Published: November 09, 2021
Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.
Journal: Clinical rheumatology
Published: February 01, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026